BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23551881)

  • 1. Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes.
    Shankar RK; Ellard S; Standiford D; Pihoker C; Gilliam LK; Hattersley A; Dolan LM
    Pediatr Diabetes; 2013 Nov; 14(7):535-8. PubMed ID: 23551881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
    Stanescu DE; Hughes N; Kaplan B; Stanley CA; De León DD
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies.
    Carette C; Dubois-Laforgue D; Saint-Martin C; Clauin S; Beaufils S; Larger E; Sola A; Mosnier-Pudar H; Timsit J; Bellanné-Chantelot C
    Diabet Med; 2010 Dec; 27(12):1454-8. PubMed ID: 21105491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
    Pearson ER; Boj SF; Steele AM; Barrett T; Stals K; Shield JP; Ellard S; Ferrer J; Hattersley AT
    PLoS Med; 2007 Apr; 4(4):e118. PubMed ID: 17407387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report.
    Forlani G; Zucchini S; Di Rocco A; Di Luzio R; Scipione M; Marasco E; Romeo G; Marchesini G; Mantovani V
    Diabetes Care; 2010 Nov; 33(11):2336-8. PubMed ID: 20705777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HNF4A Mutation p.T130I and HNF1A Mutations p.I27L and p.S487N in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes.
    Yang Y; Zhou TC; Liu YY; Li X; Wang WX; Irwin DM; Zhang YP
    J Diabetes Res; 2016; 2016():3582616. PubMed ID: 26981542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterization of maturity onset-diabetes of the young caused by hepatocyte nuclear factor-4 alpha mutation: red flags for prediction of the diagnosis.
    Mohamed S; Elkholy S; El-Meleagy E; Abu-Amero K; Hellani AM
    Ann Saudi Med; 2014; 34(3):217-21. PubMed ID: 25266181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
    Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
    Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
    Ekholm E; Shaat N; Holst JJ
    Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
    Pihoker C; Gilliam LK; Ellard S; Dabelea D; Davis C; Dolan LM; Greenbaum CJ; Imperatore G; Lawrence JM; Marcovina SM; Mayer-Davis E; Rodriguez BL; Steck AK; Williams DE; Hattersley AT;
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4055-62. PubMed ID: 23771925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
    Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
    Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young.
    Beijers HJ; Losekoot M; Odink RJ; Bravenboer B
    Diabet Med; 2009 Nov; 26(11):1172-4. PubMed ID: 19929997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.